Search results
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Pharmaceutical Technology via Yahoo Finance· 2 months agoThe top 20 biopharmaceutical companies witnessed a promising first quarter (Q1) this year amid...
Bayer (BAYRY) Partners Twist Bioscience for Drug Discovery
Zacks via Yahoo Finance· 9 months agoBayer AG BAYRY entered into an antibody discovery, option and license agreement with Twist...
Kodiak (KOD) Advances With Tarcocimab Amid Stiff Competition
Zacks via Yahoo Finance· 1 year agoKodiak (KOD) focuses on completing ongoing studies on tarcocimab for several retinal indications....
Where Will AbbVie Be in 5 Years?
Motley Fool· 1 year agoOn paper, drugmaker AbbVie (NYSE: ABBV) isn't having the best year. The company recently lost patent exclusivity in the U.S for its biggest cash cow,...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2022 Earnings Call Transcript (Corrected)
Insider Monkey via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2022 Earnings Call Transcript February 3, 2023...
2 Biotech Stocks You Can Buy and Hold for the Next Decade
Motley Fool· 1 year agoThe U.S. market is highly likely to deliver attractive returns over periods of five years or more....
Stocks on the Launchpad: The Next 3 Market Sensations
InvestorPlace via Yahoo Finance· 4 months agoIn the current bullish stock market, it’s an exhilarating period for savvy investors betting on the...
Does an FDA Fast Track Designation Make Regenxbio Stock a Buy Now?
Motley Fool· 1 year agoRegenxbio (NASDAQ: RGNX) is a clinical-stage biotech company that focuses on gene therapies based on...